A programme looking to advance the understanding of how cancer develops has been backed with £50 million. Global biopharma company GSK has invested up to £50 million in a collaboration with Oxford ...
It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
GSK plc and the University of Oxford (Oxford) announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer ...
The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
New cancer vaccine to stop disease before it takes hold in the body - Pharmaceutical giant GSK and the University of Oxford ...
(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...